Glycopyrrolate Injection, Solution
Product Images NDC 55150-293

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 55150-293). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Auromedics Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (0.2 mg per mL)

Package Label-principal Display Panel (0.2 mg per mL)
Glycopyrrolate Injection, USP 0.2 mg per mL in a 1 mL single dose vial. Label indicates use for intramuscular (IM) or intravenous (IV) administration. Contains benzyl alcohol and is labeled as not for use in newborns. Manufactured in India for AuroMedics Pharma LLC, East Windsor, NJ.*
FDA Label Image

Package Label-principal Display Panel (0.2 mg per mL)

Package Label-principal Display Panel (0.2 mg per mL)
The packaging label for Glycopyrrolate Injection, USP 0.2 mg per mL, sterile solution for intramuscular or intravenous use. The label indicates 25 single-dose vials, each 1 mL. It includes warnings such as 'Not for use in newborns' and 'Contains benzyl alcohol.' Distributed by AuroMedics Pharma LLC, with storage instructions and component details on the label.*
FDA Label Image

Package Label-principal Display Panel (0.4 mg per 2 mL (0.2 mg / mL))

Package Label-principal Display Panel (0.4 mg per 2 mL (0.2 mg / mL))
Label for Glycopyrrolate Injection, USP 0.4 mg per 2 mL (0.2 mg/mL) in a 2 mL single dose vial. The injection is for intramuscular or intravenous use, prescription only. Label indicates it contains benzyl alcohol and is manufactured in India for AuroMedics Pharma LLC, East Windsor, NJ.*
FDA Label Image

Package Label-principal Display Panel (0.4 mg per 2 mL (0.2 mg / mL))

Package Label-principal Display Panel (0.4 mg per 2 mL (0.2 mg / mL))
The image shows the carton label for Glycopyrrolate Injection, USP in a 0.4 mg per 2 mL strength (0.2 mg/mL) solution form for intramuscular or intravenous use. The carton contains 25 single-dose 2 mL vials. It states that the product is not for use in newborns and contains benzyl alcohol. The labeler is AuroMedics Pharma LLC, and storage instructions indicate keeping the product between 20° to 25°C.*
FDA Label Image

Package Label-principal Display Panel (1 mg per 5 mL (0.2 mg / mL))

Package Label-principal Display Panel (1 mg per 5 mL (0.2 mg / mL))
Label for Glycopyrrolate Injection, USP 0.2 mg/mL (1 mg per 5 mL), a solution for intramuscular or intravenous use. The label states it contains benzyl alcohol as a preservative, is a 5 mL multiple-dose vial, and is labeled for human prescription use by AuroMedics Pharma LLC.*
FDA Label Image

Package Label-principal Display Panel (1 mg per 5 mL (0.2 mg / mL))

Package Label-principal Display Panel (1 mg per 5 mL (0.2 mg / mL))
Packaging label for Glycopyrrolate Injection, USP 0.2 mg/mL (1 mg per 5 mL) solution for injection. It is indicated for intramuscular or intravenous use and contains benzyl alcohol as a preservative. The package contains 25 multiple dose vials of 5 mL each. Distributed by AuroMedics Pharma LLC.*
FDA Label Image

Package Label-principal Display Panel (4 mg per 20 mL (0.2 mg / mL))

Package Label-principal Display Panel (4 mg per 20 mL (0.2 mg / mL))
Label for Glycopyrrolate Injection, USP 0.2 mg/mL (4 mg per 20 mL) solution for injection, available in a 20 mL multiple dose vial. The label states it is for intramuscular or intravenous use, distributed by AuroMedics Pharma LLC, and contains benzyl alcohol as a preservative. Storage instructions and manufacturer details (Made in India) are also included.*
FDA Label Image

Package Label-principal Display Panel (4 mg per 20 mL (0.2 mg / mL))

Package Label-principal Display Panel (4 mg per 20 mL (0.2 mg / mL))
Packaging label for Glycopyrrolate Injection, USP 4 mg per 20 mL (0.2 mg/mL) by AuroMedics Pharma LLC. The label states it is for intramuscular or intravenous use, not for use in newborns, and contains benzyl alcohol. The package includes 25 multiple dose vials of 20 mL each. Storage and component details are also included.*
FDA Label Image

Glycopyrrolate Chemical Structure (Glycopyrrolate Str)

Glycopyrrolate Chemical Structure (Glycopyrrolate Str)
Chemical structure of glycopyrrolate, showing its molecular formula C19H28BrNO3 and molecular weight of 398.33.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.